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Abstract 
 
Objectives:  The aim of these analyses was to examine the association of cortisol, 
dehydroepiandrosterone-sulphate (DHEAS), and the cortisol:DHEAS ratio with the Metabolic 
Syndrome (MetS) and its components.  Design: The analyses were cross-sectional.  Methods: 
Participants were 4255 Vietnam era US army veterans. From military service files, telephone 
interviews, and a medical examination, occupational, socio-demographic, and health data were 
collected.  MetS was ascertained from data on: body mass index; fasting blood glucose or a diabetes 
medication; blood pressure or a diagnosis of hypertension; HDL cholesterol; and triglyceride levels.  
Contemporary morning fasted cortisol and DHEAS concentrations were determined.  The outcomes 
were MetS and its components. Analysis was by logistic regression, first adjusting for age and then 
additionally for an array of candidate confounders.  Results: Cortisol, although not in the fully 
adjusted analysis, and DHEAS were both related to MetS.  Whereas high cortisol concentrations were 
associated with an increased risk of MetS, high DHEAS concentrations appeared protective.  By far 
the strongest associations with MetS were observed for the cortisol:DHEAS ratio; the higher the ratio 
the greater the risk of having MetS. The ratio was also significantly related to four of the five MetS 
components.  Conclusions: The cortisol:DHEAS ratio is positively associated with MetS. 
Prospective analyses are needed to help untangle direction of causality, but this study suggests that 
the cortisol:DHEAS ratio is worthy of further study in this and other health contexts.  
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The metabolic syndrome (MetS) is a cluster of symptoms (obesity, high triglycerides, low HDL 
cholesterol, raised blood pressure, and high fasting blood glucose or a diagnosis of diabetes) that 
increase the risk of cardiovascular and all-cause mortality 1-4.  It is estimated that one quarter of the 
world’s adult population has the MetS 5.  The overlap between presenting clinical features of MetS and 
Cushing’s disease has prompted the hypothesis that elevated cortisol may have an aetiological role in 
the development of MetS 5, 6.  Indeed, circulating cortisol concentrations are higher in individuals with 
MetS and its components 7-11.  However, some studies have reported no association between cortisol 
and MetS 12, 13.   
     There is even less consensus about whether dehydroepiandrosterone- sulphate (DHEAS), the most 
abundant steroid in the human circulation, is implicated in MetS.  Some data suggest that lower 
DHEAS concentrations characterize individuals with MetS 14, but, again, this is not a universal 
observation 12, 13.  In addition, no studies have examined the cortisol:DHEAS ratio in this context.  
Both cortisol and DHEAS are synthesized within the adrenal cortex and it is conceivable that their 
respective relative contributions to adrenal steroid output might define observed biological action.  
Further the cortisol:DHEAS ratio has been found to predict health outcomes better than the level of 
either hormone alone 15 as well as predicting all-cause mortality 16.  Given the absence of data for the 
cortisol:DHEAS, the variable outcomes for cortisol and DHEAS and the importance of establishing 
the pathways leading to MetS, the present analyses of data from a substantial cohort of Vietnam-era 
US veterans addressed the issue of whether cortisol and DHEAS, and their ratio are associated with 
MetS.   
 
Materials and Methods  
Sample 
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     Participants were male Vietnam era military veterans recruited as part of the Centers for Disease 
Control Vietnam Experience Study 17.  The effective sample size was 4255.  Ethical approval for the 
study was given by various bodies, including the US Centers for Disease Control and participants gave 
informed consent.  Details of sampling at each stage of data collection are described in detail 
elsewhere 17.  Inclusion criteria were: entered military service between January 1, 1965 and December 
31, 1971; served only one term of enlistment and at least 16 weeks of active duty; earned a military 
specialty other than “trainee” or “duty soldier”; had a military pay grade at discharge no higher than 
sergeant.   
 
Data collection 
     Information on place of service and ethnicity was extracted from the military archives.  From a 
telephone survey in 1985, socio-economic position was measured using household income in midlife 
and the grade from which participants left school.  Alcohol consumption, smoking habits, and marital 
status were ascertained using standard questions.  In 1986, participants underwent a thorough medical 
examination.  Mean age at medical examination was 38.3 yr. (range: 31.1 to 49.0).  Participants fasted 
from 7 pm on the previous evening until blood was drawn the following morning.  Cortisol and 
DHEAS were assessed in 1986 from serum using a double antibody radioimmunoassay system (Leeco 
Diagnostics, Inc, Southfield, MI).  From the fasted blood sample, triglycerides and cholesterol 
fractions were assessed using a Kodak Ektachem 700 autoanalyzer 18, 19.  Serum glucose level was 
determined with an adaptation of the glucose oxidase-peroxidase-chromogen-coupled system 18, 19.  
Blood pressure was measured twice in the right arm using a sphygmomanometer and an average 
computed.  Height and weight were measured to calculate body mass index (BMI, kg/m2).      
     MetS and its components were defined as having at least three of the following characteristics: 
triglycerides ≥ 1.7 mmol/l (150 mg/dl); HDL cholesterol < 1.036 mmol/l (40 mg/dl); blood pressure ≥ 
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130/85 mmHg or taking antihypertensive medication; BMI > 30 kg/m2 (in the absence of waist 
circumference data, BMI at this threshold is regarded by World Health Organization and the 
International Diabetes Federation as an acceptable substitute in defining MetS 20); triglycerides ≥ 1.7 
mmol/L (150 mg/L); HDL cholesterol < 1.036 mmol/L (40 mg/L); blood pressure ≥ 130/85 mmHg or 
taking antihypertensive medication; fasting glucose ≥ 6.1 mmol/l (110 mg/dl) using the National 
Cholesterol Education Program Adult Treatment Panel III criteria21 or taking diabetes medication.  All 
laboratory assays were assured by using bench and blind repeat controls.  In 677 randomly chosen 
samples repeat sample correlations exceeded 0.98.  Bench controls yielded intra- and inter-assay 
coefficients of variation that were all < 10%.  Finally, current medication status was also determined at 
the medical examination.  
 
Statistical analysis 
     Cortisol, DHEAS and cortisol:DHEAS ratio values were not normally distributed so were natural 
log-transformed.  Demographic, service, health behaviour, metabolic, and haemodynamic variables 
were compared between those with and without MetS using χ2 and ANOVAs.  Logistic regression was 
used to examine the relationships between cortisol, DHEAS, their ratio and MetS, first in age-adjusted 
analyses and then in fully-adjusted analyses with the additional covariates of place of service, 
ethnicity, marital status, alcohol consumption, smoking, household income, and education grade.  
Further fully adjusted regression models were tested in which both cortisol and the cortisol:DHEAS 
ratio were entered in one case and DHEAS and the cortisol:DHEAS ratio in the other.  The association 
between the cortisol:DHEAS ratio and the individual MetS components was examined in further fully 
adjusted models.  Linear regression, with full adjustment, was used to test the relationship between the 
ratio and the number of MetS components participants possessed. 
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Results 
     Five hundred and eighty-four (14%) of the men were identified as having MetS.  Aside from 
differing on all the components of MetS, participants with MetS were slightly older, tended to have a 
briefer education, were less likely to be divorced, widowed or separated and more likely to come from 
ethnic groups other than white or black (Table 1).   
     In age-adjusted logistic regression analyses, men with higher morning cortisol levels were more 
likely to exhibit MetS, OR = 1.35, 95%CI 1.01 – 1.81, p = .04.  Higher DHEAS, on the other hand, 
was associated with significantly reduced incidence of MetS, OR = 0.55, 95%CI 0.45 – 0.68, p < .001.  
Those with higher cortisol:DHEAS ratios were much more likely to meet the criteria for MetS, OR = 
1.75, 95%CI 1.47 – 2.09, p < .001.  This association between the cortisol:DHEAS ratio and MetS is 
illustrated Figure 1, which shows a clear dose-response relationship.  In the fully adjusted analyses, the 
association between cortisol and MetS was no longer statistically significant at conventional levels, 
OR = 1.31, 95%CI 0.98 – 1.76, p = .07.  However, higher DHEAS concentrations were still 
negatively, OR = 0.56, 95%CI 0.46 – 0.69, p < .001, and the cortisol:DHEAS ratio still positively, OR 
= 1.72, 95%CI 1.44 – 2.05, p < .001, related to MetS.  In fully and mutually-adjusted models, the first 
entering both cortisol and the cortisol:DHEAS ratio and the second entering DHEAS and the 
cortisol:DHEAS ratio, only the ratio emerged as a significant predictor of MetS, OR = 1.83, 95%CI 
1.50 – 2.25, p < .001 and OR = 1.46, 95%CI 1.09 – 1.96, p = .01, respectively.  The statistics for 
cortisol and DHEAS in these models were OR = 0.79, 95%CI 0.57 – 1.11, p = .18 and OR = 0.79, 
95%CI 0.57 – 1.11, p = .18, respectively. 
    The cortisol:DHEAS ratio was also significantly associated with the number of components of MetS 
that a participant possessed, β = .12, t = 7.86, p <.001, ΔR2 = .014.  Finally, of the components of MetS, 
the cortisol:DHEAS ratio was positively and significantly associated with high blood pressure, OR = 
1.39, 95%CI 1.20 – 1.60, p < .001, high blood glucose, OR = 1.68, 95%CI 1.43 – 1.98, p < .001, high 
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triglycerides, OR = 1.87, 95%CI 1.59 – 2.19, p < .001, and low HDL, OR = 1.19, 95%CI 1.04 – 1.35, p = 
.009, in fully adjusted models.  The association between the cortisol:DHEAS ratio and obesity was only a 
trend, OR = 1.17, 95%CI 0.98 – 1.41, p = .09.  When these fully-adjusted analyses were rerun with 
adjustment for obesity, the cortisol:DHEAS ratio remained significantly associated with high blood 
pressure, OR = 1.38 CI 1.19 - 1.59 p<.001; high triglycerides, OR = 1.88 CI 1.60 - 2.21, p<.001; 
low HDL OR = 1.17 CI 1.02 - 1.33, p = .02; and high blood glucose, OR = 1.67 CI 1.41 - 1.97, p 
<.001. 
 
[Insert Table 1 and Figure 1 about here] 
 
     Discussion 
Cortisol, although not in the fully adjusted analysis, and DHEAS were both related to MetS; whereas 
high cortisol concentrations were associated with an increased risk of MetS, high DHEAS 
concentrations appeared protective.  These outcomes, in what we believe is the largest study 
conducted to date, agree with some 7-11, 14, but not all 12, 13 of the existing literature.  By far the most 
robust associations with MetS were observed for the cortisol:DHEAS ratio; the higher the ratio the 
greater the risk of having MetS.  In mutually-adjusted analyses, only the ratio emerged as a significant 
predictor of MetS.  The cortisol:DHEAS ratio was also positively associated with the number of 
components of MetS, as well as with four of the five MetS components.  This extends previous 
research showing that the cortisol:DHEAS ratio was associated with all-cause mortality 16.  It also 
predicts immune function and infectious disease susceptibility better than either hormone alone 15, 22.  
Thus, the cortisol:DHEAS ratio merits examination in the context of other health outcomes.    
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     With cross-sectional analyses it is impossible to determine causality and direction of the 
association.  For example, it has been suggested that MetS may lead to a state of hypercortisolism, but 
there is also evidence that increased exposure to cortisol contributes to increased fat accumulation in 
the visceral depots 5.  The protective effect indicated by higher DHEAS is particularly interesting and 
the anti-glucocorticoid actions of its precursor, DHEA, are well documented 23-25.  Higher levels of 
DHEA or DHEAS might lead to lower effective cortisol action, particularly at a tissue-specific level, 
e.g. adipose tissue, immune cells 26.  Indeed our own in vitro data has shown that DHEAS can 
overcome the suppressive  effects of cortisol upon immune cell function, specifically the generation of 
superoxide by neutrophils15,  supporting the proposal that it is the ratio of these two hormones that will 
determine biological outcome in vivo 27.  Moreover, there are no reports of MetS suppressing DHEAS 
production, supporting the notion that the direction of causality is from a lower ratio to MetS.  Both 
cortisol and DHEA/DHEAS secretion are under the regulatory influence of pituitary ACTH, and 
excessive glucocorticoid production will lead to a down-regulation of ACTH, resulting in reduced 
DHEA secretion, as frequently observed in patients with an adrenal cortisol-producing adenoma.  
However, the circulating cortisol levels measured in this cohort are not unusually elevated.  Thus, a 
suppressive influence of cortisol on DHEAS secretion seems unlikely.  It may also be the case that 
both hormonal profile and susceptibility to MetS reflect programming effects in early life consequent 
on prenatal resource deprivation 6.  However, it must be emphasized that such considerations remain 
speculative given the cross-sectional nature of the study; only prospective and experimental studies 
can resolve issues of causality.   
     The present study may have other limitations.  First, the sample was exclusively male and relatively 
young, so the findings may not be able to be generalized to the women and older populations.  
However, the sex hormone binding globulin has been found to be associated with MetS in both sexes 
12, 13.  Nonetheless, as premenopausal women have slightly higher total cortisol values and lower 
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circulating DHEAS 28, it would be interesting to examine the influence of the cortisol:DHEAS ratio 
and MetS in women where the relationship could be even stronger.  The relative youth of our sample 
is most likely the reason for the relatively low prevalence of MetS.  However, given that the 
prevalence of MetS is generally higher in older individuals 29, it is possible that the associations 
observed would be even stronger in an older sample.  It is also worth noting that the cortisol:DHEAS 
ratio increases with age 30, thus is likely to be an even stronger predictor of MetS in an older sample.  
The second possible limitation is the use of a single morning measurement of serum cortisol and 
DHEAS.  Cortisol has a diurnal rhythm which would be best captured through multiple measurements 
of the free active fraction of cortisol, such as can be determined through saliva sampling.  Further, the 
most accurate assessment for assessing silent hypercortisolism is by an overnight dexamethasone 
suppression test.  However, the timing of the present samples was fairly consistent across participants.  
Further, DHEAS concentrations remain stable throughout the day and reflect the 24-hour secretion of 
DHEA 31, 32.   
     In conclusion, the cortisol:DHEAS ratio was positively associated with MetS and many of its 
components.  Prospective research is required to clarify the causal direction of this relationship and 
inform future intervention strategies.  In addition, it would be worthwhile examining the 
cortisol:DHEAS ratio in the context of other health outcomes.  
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Table 1. Characteristics of participants with and without metabolic syndrome 
 Metabolic syndrome 
(N = 584) 
No metabolic syndrome  
(N = 3671) 
p 
 
 Mean SD Mean SD  
Metabolic Syndrome Markers:      
BMI (kg/m2)  30.73 4.15 25.17 3.04 <.001 
Triglycerides (mmol/L) 2.56 2.43 1.09 0.73 <.001 
HDL cholesterol (mmol/L) 0.89 0.20 1.19 0.31 <.001 
SBP (mmHg) 133.33 12.50 121.36 11.11 <.001 
DBP (mmHg) 91.85 9.29 82.88 8.84 <.001 
Blood glucose (mmol/L) 5.93 1.71 5.13 0.70 <.001 
Predictor Variables:      
Cortisol (mmol/L) 0.52 0.17 0.50 0.15  .002 
DHEAS (mmol/L) 5.88 2.49 6.62 2.73 <.001 
Cortisol:DHEAS ratio 0.102 0.06 0.088 0.05 <.001 
Covariates:      
Age at medical examination (years) 38.74 2.52 38.26 2.51 <.001 
Units of alcohol per week 7.28 16.78 7.05 14.01  .72 
 N (%) N (%) p 
Metabolic Syndrome Markers:    
Obese 347 (59) 203 (6) <.001 
Hypertension diagnosis                 169 (29) 271 (7) <.001 
Diabetes diagnosis                                24 (4) 25 (1) <.001 
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Covariates:    
Place of service                            Ever in Vietnam 
                                              Other overseas 
                                                        US only
339 (58) 
142 (24) 
103 (18) 
2009 (55) 
953 (26) 
709 (19) 
.32 
 
Ethnicity                                                          White 
                                                            Black 
                                                            Other  
473 (81) 
60 (10) 
51 (9) 
3017 (82) 
435 (12) 
219 (6) 
 .03 
 
Household income in midlife                     <$20,000 
                                                       -$40,000 
                                                      >$40,000
183 (31) 
289 (50) 
112 (19) 
1018 (28) 
1840 (50) 
813 (22) 
.11 
Years in education                                       <11 
                                                                      -12 
                                                                     >12 
93 (16) 
218 (37) 
273 (47) 
419 (11) 
1346 (37) 
1906 (52) 
.004 
Smoking status                                      Non smoker 
                                                     Ex smoker 
                                             Current smoker
146 (25) 
166 (28) 
272 (47) 
938 (26) 
1043 (28) 
1690 (46) 
.96 
 
Marital status                                                Married 
                       Divorced/separated/widowed 
                                               Never married
459 (79) 
79 (13) 
46 (8) 
2672 (73) 
688 (19) 
314 (8) 
.006 
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Figure 1: Prevalence of MetS according to quartiles of the cortisol:DHEAS ratio (1 = 0.01 – 0.06; 2 = to 
0.08; 3 = to 0.11; 4 = to 0.73). 
 
 
 
